Related Experiment Video
Updated: May 26, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
The prophylactic use of recombinant factor VIIa in a patient with DeBakey type III aortic dissection -A case report-
Wook Jong Kim1, Jin-Young Oh, Hyo Jung Son
1Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Little is known about the prophylactic use of recombinant factor VIIa (rFVIIa) in patients undergoing surgery for a bleeding aorta employing cardiopulmonary bypass. We report the successful use of rFVIIa in a patient undergoing hypothermic circulatory arrest and prolonged cardiopulmonary bypass for repair of a DeBakey type III aortic dissection.
Little is known about the prophylactic use of recombinant factor VIIa (rFVIIa) in patients undergoing surgery for a bleeding aorta employing cardiopulmonary bypass. We report the successful use of rFVIIa in a patient undergoing hypothermic circulatory arrest and prolonged cardiopulmonary bypass for repair of a DeBakey type III aortic dissection.
Related Concept Videos
Aneurysm III: Interprofessional Care
Rheumatic Heart Disease III: Medical Management
Aortic Regurgitation III: Medical Management
Venous Thrombosis III: Interprofessional Care
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management